Page last updated: 2024-10-20

sarcosine and Neoplasms

sarcosine has been researched along with Neoplasms in 10 studies

cocobetaine: N-alkyl-betaine; cause of shampoo dermatitis

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"GSK923295 is an inhibitor of CENP-E, a key cellular protein important in the alignment of chromosomes during mitosis."2.77First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. ( Botbyl, JD; Chung, V; Heath, EI; Holen, KD; Johnson, BM; Kirby, LC; Lampkin, TA; Lynch, KM; Schelman, WR, 2012)
"We used datasets from the Cancer Cell Line Encyclopedia (CCLE) phase II project and treated metabolomic data as tensor predictors and data on gene expression of metabolic enzymes as confounding covariates."1.91Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers. ( Huang, TH; Li, CI; Lin, PC; Shen, MR; Tsai, YS; Yeh, YM, 2023)
"Sarcosine-treated DC vaccines resulted in significantly improved tumor control in a B16F10-OVA tumor flank model and improved survival in an intracranial GL261-gp100 glioma model."1.51Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. ( Azari, H; Dastmalchi, F; Dechkovskaia, A; Karachi, A; Lovaton, RE; Mitchell, DA; Rahman, M; Saia, ME; Sayour, EJ; Vlasak, AL; Yang, C, 2019)
"NIRF imaging of a small cancer on mouse by using the peptosome as a nanocarrier was successful due to the EPR effect of the peptosome."1.35Near-infrared fluorescent labeled peptosome for application to cancer imaging. ( Hiraoka, M; Kimura, S; Kizaka-Kondoh, S; Makino, A; Tanaka, S; Tanisaka, H, 2008)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Li, CI1
Yeh, YM1
Tsai, YS1
Huang, TH1
Shen, MR1
Lin, PC1
Dastmalchi, F1
Karachi, A1
Yang, C1
Azari, H1
Sayour, EJ1
Dechkovskaia, A1
Vlasak, AL1
Saia, ME1
Lovaton, RE1
Mitchell, DA1
Rahman, M1
Hu, Y1
Hou, Y1
Wang, H1
Lu, H1
Lee, WH1
Liu, HE1
Chang, JY1
Liou, JP1
Huang, HM1
Zhu, H1
Chen, Y1
Yan, FJ1
Chen, J1
Tao, XF1
Ling, J1
Yang, B1
He, QJ1
Mao, ZW1
Sano, K1
Ohashi, M1
Kanazaki, K1
Makino, A4
Ding, N1
Deguchi, J1
Kanada, Y1
Ono, M1
Saji, H1
Kizaka-Kondoh, S2
Yamahara, R2
Hara, I2
Kanzaki, T1
Ozeki, E2
Hiraoka, M2
Kimura, S3
Chung, V1
Heath, EI1
Schelman, WR1
Johnson, BM1
Kirby, LC1
Lynch, KM1
Botbyl, JD1
Lampkin, TA1
Holen, KD1
Hara, E1
Kurihara, K1
Yamamoto, F1
Tanisaka, H1
Tanaka, S1

Trials

1 trial available for sarcosine and Neoplasms

ArticleYear
First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:3

    Topics: Adult; Aged; Antimitotic Agents; Bridged Bicyclo Compounds, Heterocyclic; Chromosomal Proteins, Non-

2012

Other Studies

9 other studies available for sarcosine and Neoplasms

ArticleYear
Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers.
    Human genomics, 2023, 03-06, Volume: 17, Issue:1

    Topics: Biomarkers, Tumor; Gene Expression; Glyceric Acids; Humans; Microsatellite Instability; Neoplasms; S

2023
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
    Journal for immunotherapy of cancer, 2019, 11-21, Volume: 7, Issue:1

    Topics: Adoptive Transfer; Animals; Biomarkers; Cancer Vaccines; Cell Movement; Dendritic Cells; Disease Mod

2019
Polysarcosine as an Alternative to PEG for Therapeutic Protein Conjugation.
    Bioconjugate chemistry, 2018, 07-18, Volume: 29, Issue:7

    Topics: Animals; Antibody Formation; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Interferon

2018
MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells.
    Pharmacology, 2013, Volume: 92, Issue:1-2

    Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm;

2013
Polysarcosine brush stabilized gold nanorods for in vivo near-infrared photothermal tumor therapy.
    Acta biomaterialia, 2017, 03-01, Volume: 50

    Topics: A549 Cells; Animals; Biocompatible Materials; Blood Circulation; Cell Survival; Colloids; Gold; Hype

2017
Indocyanine Green-Labeled Polysarcosine for in Vivo Photoacoustic Tumor Imaging.
    Bioconjugate chemistry, 2017, 04-19, Volume: 28, Issue:4

    Topics: Animals; Cell Line, Tumor; Endocytosis; Humans; Indocyanine Green; Mice; Neoplasms; Peptides; Photoa

2017
Near-infrared fluorescence tumor imaging using nanocarrier composed of poly(L-lactic acid)-block-poly(sarcosine) amphiphilic polydepsipeptide.
    Biomaterials, 2009, Volume: 30, Issue:28

    Topics: Animals; Cell Line, Tumor; Diagnostic Imaging; Fluorescence; Humans; Lactic Acid; Male; Mice; Mice,

2009
Control of in vivo blood clearance time of polymeric micelle by stereochemistry of amphiphilic polydepsipeptides.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Aug-10, Volume: 161, Issue:3

    Topics: Animals; Cell Line; Depsipeptides; Fluorescent Dyes; Humans; Indocyanine Green; Lactic Acid; Mice; M

2012
Near-infrared fluorescent labeled peptosome for application to cancer imaging.
    Bioconjugate chemistry, 2008, Volume: 19, Issue:1

    Topics: Animals; Circular Dichroism; Drug Carriers; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Infrared

2008